NCT00218426
- Conditions
- Chemically-Induced Disorders, Heroin Dependence, Mental Disorders, +4 more
- Locations
-
- University of Pennsylvania Philadelphia, Pennsylvania, United States
- Pavlov Medical University Saint Petersburg, Russia
Clinical trial condition
Narcotic-Related Disorders
Explore clinical trials studying Narcotic-Related Disorders. Study availability and eligibility vary by location and protocol.
1,300 public trials
198 recruiting studies
Narcotic-Related Disorders trial results
NCT02537574
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- North Country Clinical Research Oceanside, California, United States
- NRC Research Institute Orange, California, United States
- Atlantic Shores Hospital Lauderhill, Florida, United States
- TRY Research Maitland, Florida, United States
NCT03715634
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- Quotient Sciences Ruddington, Nottingham, United Kingdom
NCT02696434
- Conditions
- Behavior, Behavior, Addictive, Chemically-Induced Disorders, +7 more
- Locations
-
- Segal Institute for Clinical Research Lauderhill, Florida, United States
- Research Centers of America, LLC Oakland Park, Florida, United States
- Neuroscience Research Institute, Inc. Winfield, Illinois, United States
- John Hopkins School of Medicine Baltimore, Maryland, United States
Completed
Pupil Response in Patients on Opioids.
NCT02247024
- Conditions
- Chemically-Induced Disorders, Chronic Pain, Impaired Pupillary Reflex, +9 more
- Locations
-
- Oslo University Hospital, The Norwegian Radium Hospital Oslo, Norway
- The Norwegian Radium Hospital Oslo, Norway
NCT03048643
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Buprenorphine, +13 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
NCT00555425
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- The APT Foundation, Inc. -- Welch Building New Haven, Connecticut, United States
- Yale University School of Medicine New Haven, Connecticut, United States
NCT02180659
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
Not specified
Completed
Impact of Delta Opioid Receptor Gene (OPRD1) Variations on Treatment Outcome in African Americans
NCT02225184
- Conditions
- Chemically-Induced Disorders, Drug Abuse/Dependence, Genetic Underpinning of Substance Abuse, +6 more
- Locations
-
- National Institute on Drug Abuse Baltimore, Maryland, United States
NCT01262261
- Conditions
- Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
- Locations
-
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Synergy Clinical Research Center National City, California, United States
- North County Clinical Research Oceanside, California, United States
- Friends Research Institute Torrance, California, United States